NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Price Target Raised to C$6.00

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its target price increased by Royal Bank Of Canada from C$5.50 to C$6.00 in a research note issued to investors on Wednesday morning,BayStreet.CA reports. They currently have a sector perform rating on the stock.

A number of other equities analysts also recently weighed in on the stock. Canadian Imperial Bank of Commerce boosted their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a report on Thursday, November 13th. BMO Capital Markets raised their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a report on Thursday, November 13th. Scotiabank lifted their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research report on Thursday, November 13th. Finally, ATB Cormark Capital Markets cut shares of NorthWest Health Prop Real Est Inv Trust from an “outperform” rating to a “sector perform” rating and set a C$6.25 target price on the stock. in a research note on Friday, February 27th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, NorthWest Health Prop Real Est Inv Trust has an average rating of “Hold” and an average target price of C$6.13.

NorthWest Health Prop Real Est Inv Trust Stock Performance

NWH.UN stock opened at C$5.74 on Wednesday. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The firm has a market cap of C$1.43 billion, a PE ratio of -27.15, a P/E/G ratio of 0.74 and a beta of 1.63. The business has a 50 day moving average of C$5.65 and a 200-day moving average of C$5.31. NorthWest Health Prop Real Est Inv Trust has a 12-month low of C$4.44 and a 12-month high of C$6.07.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) last issued its quarterly earnings results on Tuesday, February 24th. The company reported C($0.16) EPS for the quarter. The business had revenue of C$102.27 million for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative return on equity of 14.67% and a negative net margin of 75.29%. As a group, sell-side analysts expect that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 earnings per share for the current year.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.